SCHEMBL5046847

SCHEMBL5046847

CCOC(=O)c1nc(-c2cc(C(=O)NCCCOC)c(C)n2Cc2ccc(OC)cc2)cs1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.49
HPGD P15428 1/20 0.49
TP53 P04637 2/20 0.43
MAPT P10636 4/20 0.43
POLB P06746 1/20 0.43
KLKB1 P03952 3/20 0.43
GAA P10253 3/20 0.42
HTT P42858 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
LMNA P02545 3/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
CRHBP P24387 1/20 0.40
CRHR2 Q13324 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
KDM4E B2RXH2 2/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
GSK3B P49841 1/20 0.38
KLK1 P06870 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6068954 0.95 ALDH1A1 (0.47) ALDH1A1HPGDTP53MAPTKLKB1
SCHEMBL5048628 0.94 HPGD (0.46) ALDH1A1HPGDTP53MAPTPOLB
SCHEMBL5043761 0.89 KLKB1 (0.44) ALDH1A1HPGDTP53MAPTKLKB1
SCHEMBL5044556 0.87 KLKB1 (0.43) ALDH1A1HPGDTP53MAPTKLKB1
SCHEMBL5047164 0.85 POLB (0.49) ALDH1A1HPGDTP53MAPTPOLB
SCHEMBL5039641 0.83 ALDH1A1 (0.52) ALDH1A1HPGDMAPTPOLBGAA
SCHEMBL5048540 0.83 ALDH1A1 (0.48) ALDH1A1HPGDPOLBGAAHTT
SCHEMBL5046032 0.82 KLKB1 (0.53) ALDH1A1HPGDTP53MAPTKLKB1
SCHEMBL6068958 0.81 ALDH1A1 (0.41) ALDH1A1HPGDTP53MAPTPOLB
SCHEMBL5048731 0.80 ALDH1A1 (0.46) ALDH1A1HPGDTP53MAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1583762-B1 PYRROLYL-THIAZOLES AND THEIR USE AS CB 1 RECEPTOR INVERSE AGONISTS HOFFMANN LA ROCHE (CH) 2008-07-09 EP disclosed
US-7135488-B2 Pyrrolyl-thiazole derivatives HOFFMANN-LA ROCHE INC. (US) 2006-11-14 US disclosed
EP-1583762-A1 PYRROLYL-THIAZOLES AND THEIR USE AS CB 1 RECEPTOR INVERSE AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2005-10-12 EP disclosed
US-20040147572-A1 Novel pyrrolyl-thiazole derivatives HOFFMAN-LA ROCHE INC. 2004-07-29 US disclosed
WO-2004060888-A1 NOVEL CB 1 RECEPTOR INVERSE AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2004-07-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040147572-A1 Novel pyrrolyl-thiazole derivatives CNR1, CNR2, NPY1R ALDH1A1 959/4885HPGD 2000/4885TP53 4443/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.